G

Grape King Bio Ltd
TWSE:1707

Watchlist Manager
Grape King Bio Ltd
TWSE:1707
Watchlist
Price: 155 TWD 0.65% Market Closed
Market Cap: 23B TWD
Have any thoughts about
Grape King Bio Ltd?
Write Note
Grape King Bio Ltd
/
Balance Sheet
/
Long-Term Investments

Grape King Bio Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Grape King Bio Ltd
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
G
Grape King Bio Ltd
TWSE:1707
Long-Term Investments
NT$1.6B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
19%
Maxigen Biotech Inc
TWSE:1783
Long-Term Investments
NT$396.1m
CAGR 3-Years
255%
CAGR 5-Years
113%
CAGR 10-Years
46%
Maywufa Co Ltd
TWSE:1731
Long-Term Investments
NT$645.9m
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
3%
Chlitina Holding Ltd
TWSE:4137
Long-Term Investments
NT$598.5m
CAGR 3-Years
-12%
CAGR 5-Years
41%
CAGR 10-Years
N/A
No Stocks Found

Grape King Bio Ltd
Glance View

Market Cap
23B TWD
Industry
Consumer products

Grape King Bio Ltd. engages in the production and sale of pharmaceutical preparations, patent medicine, liquid tonics, drinks, and healthy food. The company is headquartered in Taoyuan, Taoyuan. The firm operates through three business segments. The Direct Sales segment is engaged in the development and manufacture of related products for subsidiaries. The Distribution segment is engaged in the provision of own-brand products. The Original Equipment Manufacturer (OEM) segment is engaged in the OEM business in Taiwan and Shanghai. The main products include lactic acid bacteria products and other healthcare products, as well as beverage products, medicines and cosmetics. The firm operates in Taiwan, mainland China and other markets.

Intrinsic Value
201.27 TWD
Undervaluation 23%
Intrinsic Value
Price
G
What is Intrinsic Value?

See Also

What is Grape King Bio Ltd's Long-Term Investments?
Long-Term Investments
1.6B TWD

Based on the financial report for Jun 30, 2024, Grape King Bio Ltd's Long-Term Investments amounts to 1.6B TWD.

What is Grape King Bio Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
19%

Over the last year, the Long-Term Investments growth was 5%. The average annual Long-Term Investments growth rates for Grape King Bio Ltd have been 1% over the past three years , 1% over the past five years , and 19% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.